Pain in middle-aged men 'prostate hypertrophy', minimally invasive treatment?

Aug 08, 2024

Pain in middle-aged men 'prostate hypertrophy', minimally invasive treatment?
data photo source=Pixabay



Prostate hypertrophy is prostate due to increased prostate sizeIt is a disease with occlusion and bladder stimulation symptoms, and prostate hypertrophy is diagnosed in more than 50% of people in their 60s, and a prevalence rate of nearly 90% is reported in those in their 80s.

Changes in sex hormones and male hormone receptors in prostate cells due to age increase are known to cause prostate hypertrophy, and metabolic syndrome such as diabetes and obesity is also known to be closely related to the occurrence of prostate hypertrophy.

The main symptoms of prostatic hypertrophy are the prostate, such as the encephalopathy, the urinary tract, and the residual urineA combination of occlusion symptoms and urination symptoms related to bladder storage capacity such as frequent urination, night urination, and urgent urination significantly deteriorates the quality of life. If prostate hypertrophy is left unattended, emergency situations such as hematuria and acute urinary retention can occur, and it can lead to urinary tract infection or decreased renal function, so early detection and appropriate treatment are important.



Treatment of prostate hypertrophy can be largely divided into drug treatment and surgical treatment. Drug treatment is a method of relieving symptoms by using alpha blockers or 5α reductase inhibitors. However, drug treatment has a limitation in that there is a possibility of side effects, and the effect is insufficient if the symptoms are severe or if the prostate hypertrophy progresses a lot. As surgical treatments performed for more fundamental treatment, endoscopic surgical methods such as transurethral prostatectomy and holop surgery are recognized as standard treatment methods.

However, these treatments have problems that cause postoperative ejaculation disorders, and elderly patients have limitations in increasing the risk of surgery related to anesthesia and postoperative recovery due to the accompanying underlying diseases. Therefore, recently, minimally invasive treatments that are free from postoperative ejaculation disorders and can reduce the risk of surgery have been continuously developed, and among them, the most recently introduced 'water vaporization of the mediastinal prostate" (Rezum, Rezum) is in the spotlight as a representative minimally invasive treatment.



Rezum is a minimally invasive treatment that approaches the prostate urethra endoscopically, releases water vapor into enlarged prostate tissue, and destroys and removes prostate tissue with water vapor energy. Treatment time is as short as about 15 minutes, and it is possible under local anesthesia, and hospitalization period can be minimized, so even older patients with many underlying diseases have less risk of surgery. In addition, compared to standard surgical methods, it has the advantage of less surgery-related pain, faster recovery, and preserving sexual functions including ejaculation functions.

Professor Park Min-gu of the Department of Urology at Korea University's Anam Hospital said, "Minimal invasive treatments of the prostate, including resum, have similar effects compared to existing standard treatments and can significantly reduce the risk of surgery and side effects, which can significantly reduce the burden on patients." "Since prostate hypertrophy is a disease that progresses with age, early detection and appropriate treatment is a way to maintain a high quality of life and take care of health even in the age of 100." Therefore, it is important not to overlook the symptoms of urination that have newly emerged after middle age, and to seek immediate medical attention from a urologist."



Pain in middle-aged men 'prostate hypertrophy', minimally invasive treatment?
박민구 교수


bellho@sportschosun.com